Johnson & Johnson to Acquire V-Wave Ltd. for $600 Million, Expanding Cardiovascular Portfolio

Healthcare Technology Report September 9, 2024

On August 20, 2024, Johnson & Johnson disclosed that it has completed a definitive agreement to acquire V-Wave, a privately-held company that specializes in the development of innovative treatment options for heart failure patients. The acquisition, valued at an upfront payment of $600 million with the potential for additional milestone payments up to $1.1 billion, will integrate V-Wave...

Today's Sponsors

Today's Sponsor